How Will More Investor Cash Influence Biotech Deal-Making In 2019?
Executive Summary
Biotech companies raised more than $22bn via venture capital financing in 2018. With more cash to propel innovation and bolster R&D, traditional pharma and biotech partnering agreements are likely to evolve in the year ahead.